Notably, the Ct values in qMSP assays showed that the differentially methylated regions on Septin9, MT-1A, and Epo genes were significantly lower in EC samples compared with controls (Wilcoxon’s test, P < 0.05), indicating these potential markers had a higher methylation status in cancer samples (Figure 2B). This evidence concerns the gene EPO and cancer.